CMSH China Medical

    
  China Medical Systems Holdings Ltd
  28 October 2008
   

 For Immediate release       28 October 2008

    China Medical System Holdings Ltd. 
    ("CMS" or "the Company")
    Accredited as one of "Asia's Best Under A Billion" by Forbes
    China Medical System Holdings Ltd. (AIM: CMSH), the integrated and profitable Chinese pharmaceutical company, is pleased to announce
that the Company was recently accredited to the Forbes list of "Asia's Best 200 Under A Billion" in 2008.
    Forbes Best Under A Billion list in 2008 drew from 24,155 publicly listed companies with less than USD$1 billion in sales in the
Asia-Pacific Region. The companies were vetted for consistent growth of both sales and profits over the past 12 months. According to Forbes
Magazine, members of the 2008 list have proven themselves capable of navigating stormy economies, and their list has historically been a
good place for investors to get ideas about Asian investments. 
    Mr. Lam Kong, CEO of CMS, commented, "We are honored to be recognized by Forbes from among the thousands of companies considered, and
winning this international recognition, which is not attainable without the strong commitment and support from our shareholders, customers,
business partners and all our staff for their loyalty and dedication."
    For further information, please contact:
 China Medical System Holdings Ltd                   + (852) 2369 3889
 Vincent Hui
 Seymour Pierce Limited                           + 44 (0)20 7107 8344
 Stuart Lane / Huaizheng Peng / Christopher Wren

    Notes for editors

    Forbes Asia's 200 Best Under A Billion
    The complete list is available in the Sept. 24, 2008 issue of Forbes Asia, as well as at http://www.forbes.com/BUB .

    China Medical System Holdings Limited 
    China Medical System Holding (CMS) is listed on AIM of the London Stock Exchange with the ticker symbol "CMSH". It is an integrated and
profitable pharmaceutical company, which develops, manufactures and distributes prescription drugs in China. It focuses on distributing high
margin imported pharmaceutical products as well as developing in house drugs. For further information, please visit
www.chinamedicalsystem.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
NRAFEEFMWSASELS

Grafico Azioni China Medical (LSE:CMSH)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni China Medical (LSE:CMSH)
Storico
Da Giu 2023 a Giu 2024